Project Grant K23HL166766
- This Project Grant award from the National Heart, Lung, and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research) provides $370,452 to The Johns Hopkins University to conduct research on the impact of financial toxicity on health outcomes for individuals with chronic obstructive pulmonary disease (COPD). The study will use quantitative and qualitative methods to evaluate the association between financial toxicity, disability, health-related quality of life, and medication adherence in...
- This Project Grant award of $762,867.00 from the National Heart, Lung, and Blood Institute (CFDA 93.837 - Cardiovascular Diseases Research) aims to investigate the role of the cofilin-1 protein in regulating mitochondrial function and quality control in airway epithelial cells. The research, conducted by The Johns Hopkins University, seeks to understand how the loss of cofilin-1 impacts mitochondrial dynamics and mitophagy, and how these processes contribute to airway epithelial dysfunction in...
- This federal Project Grant award of $708,678, provided by the National Heart, Lung and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research), aims to conduct a Sequential Multiple Assignment Randomized Trial (SMART) to reduce food insecurity and improve adherence in patients with hypertension. The key products and services to be delivered under this grant include: Determining the most effective initial food insecurity intervention (resource information or community health worker...
- This Project Grant award of $609,850 from the National Heart, Lung, and Blood Institute (CFDA 93.837 - Cardiovascular Diseases Research) will fund a longitudinal study to examine food insecurity as a social determinant of cardiovascular health in a marginalized immigrant Latino population. The study will collect mixed-methods data from 450 Latino immigrants to characterize patterns of food insecurity over time and how it, along with trauma, impacts cardiovascular disease risk and psychological...
- This $237,750 Project Grant award from the National Heart, Lung, and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research) to Temple University aims to investigate the impact of an equity-focused implementation strategy on participation and uptake of Universal School Meals (USM) among students at highest risk for food insecurity and obesity. The project seeks to build on the principal investigator's existing K01 award, utilizing a multi-method approach to determine if the equity-focused...
- This federal Project Grant award of $101,360.00 was provided by the National Heart Lung and Blood Institute under the Cardiovascular Diseases Research program (CFDA 93.837) to The Johns Hopkins University. The grant will support a postdoctoral research project led by Dr. Andrew Davis that aims to use observational data and causal inference methods to develop evidence-based interventions for reducing hospital readmissions among survivors of pneumonia with respiratory failure. The project's...
- This $116,625 federal Project Grant award from the National Heart, Lung, and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research) will characterize clinically relevant phenotypes related to osteoporosis and sarcopenia in chronic obstructive pulmonary disease (COPD). The project will develop automated methods to derive static metrics of spine, vertebrae, and pectoral muscles, as well as dynamic metrics of lung diaphragmatic surface deformation, from chest CT scans. It will then use...
- This Project Grant award from the National Heart Lung and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research) provides $708,063 in funding to the University of Virginia for a research project titled "Post-Transcriptional Regulatory Networks in Chronic Obstructive Pulmonary Disease". The goal of the 5-year project is to generate RNA-binding protein (RBP) regulatory networks, identify COPD-specific changes, and characterize the functional consequences of the network changes....
- This federal Project Grant award of $805,921 from the National Heart Lung and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research) aims to integrate multi-trait, multi-ancestry, and multi-omic data from massive global biobanks to decipher the genetic mechanisms underlying respiratory diseases like chronic obstructive pulmonary disease (COPD) and asthma. The award, with a performance period from September 2025 to June 2030, will leverage data from over 2 million participants,...
- This federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), provides $477,290 to Mayo Clinic to investigate the underlying behavioral mechanisms that impact a home-based pulmonary rehabilitation program for patients with chronic obstructive pulmonary disease (COPD). The research aims to determine the associations between patterns of physical activity, sedentary behavior, sleep, and cognitive...
This federal Project Grant award, funded by the National Heart, Lung, and Blood Institute (CFDA Program 93.837 Cardiovascular Diseases Research), provides $198,654.00 to The Johns Hopkins University to investigate the association of diet quality and food insecurity with the risk of rehospitalization for individuals hospitalized for acute exacerbations of chronic obstructive pulmonary disease (AECOPD). The study aims to assess diet quality and food insecurity after hospital discharge, and conduct interviews to identify contributors to diet quality and food insecurity during the transition from hospital to home. This 5-year project, with an award date of August 1, 2025 and an ultimate completion date of July 31, 2030, seeks to identify potentially modifiable dietary factors that may influence COPD morbidity and rehospitalization risk, particularly among individuals with low socioeconomic status.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $198.7k | 7/29/25 |